Medimmune, LLC v. PDL Biopharma, Inc.

Filing 538

ORDER BY JUDGE JEREMY FOGEL GRANTING 477 515 MEDIMMUNE'S MOTION FOR LEAVE TO ASSERT COUNTERCLAIMS. (jflc1, COURT STAFF) (Filed on 6/7/2010)

Download PDF
1 2 3 4 5 6 7 8 IN THE UNITED STATES DISTRICT COURT 9 FOR THE NORTHERN DISTRICT OF CALIFORNIA 10 SAN JOSE DIVISION 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Plaintiff MedImmune, LLC ("MedImmune") moves for leave to assert "counterclaims-inreply" in its reply to Defendant PDL BilPharma, Inc.'s ("PDL") First Amended Answer, Defenses, and Counterclaims. On May 21, 2010, PDL filed a statement of non-opposition to the motion. Pursuant to Civil Local Rule 7-1(b), the Court has determined that the motion is appropriate for determination without oral argument. Having reviewed the moving papers, the Court concludes that the motion is well-taken. Accordingly, the motion is GRANTED. The hearing date on the motion is hereby vacated. IT IS SO ORDERED. DATED: 6/7/10 __________________________________ JEREMY FOGEL United States District Judge C a s e Number C 08-5590 JF (HRL) O R D E R GRANTING MEDIMMUNE'S MOTION FOR LEAVE TO ASSERT COUNTERCLAIMS ( JF L C 1 ) **E-Filed 6/7/2010** MEDIMMUNE, LLC, Plaintiff, v. PDL BIOPHARMA, INC., Case Number C 08-5590 JF (HRL) ORDER GRANTING MEDIMMUNE'S MOTION FOR LEAVE TO ASSERT COUNTERCLAIMS re: documents no. 477, 515 Defendant.

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?